Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncocyte Corp | Former CEO, Director | Common Stock, no par value | 583K | $125K | $0.21 | Dec 1, 2022 | Direct |
Precipio, Inc. | Director | Common Stock | 11.1K | $73.7K | $6.62 | Oct 15, 2024 | Direct |
Oncocyte Corp | Former CEO, Director | Option to Purchase Common Stock | 50K | Dec 7, 2022 | Direct | ||
Precipio, Inc. | Director | Stock Option (Right to Buy) | 2K | Aug 31, 2024 | Direct | ||
Oncocyte Corp | Former CEO, Director | Restricted Stock Units | 0 | Dec 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRPO | Precipio, Inc. | Oct 15, 2024 | 1 | $10K | 4 | Oct 17, 2024 | Director |
PRPO | Precipio, Inc. | Aug 31, 2024 | 8 | $0 | 4 | Sep 6, 2024 | Director |
PRPO | Precipio, Inc. | Jul 15, 2024 | 1 | $9.99K | 4 | Jul 16, 2024 | Director |
PRPO | Precipio, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
PRPO | Precipio, Inc. | Apr 15, 2024 | 1 | $21K | 4 | Apr 17, 2024 | Director |
PRPO | Precipio, Inc. | Oct 24, 2023 | 1 | $0 | 4 | Oct 26, 2023 | Director |
PRPO | Precipio, Inc. | Sep 12, 2023 | 1 | $0 | 4 | Sep 14, 2023 | Director |
PRPO | Precipio, Inc. | Jan 6, 2023 | 1 | $0 | 4 | Jan 10, 2023 | Director |
OCX | Oncocyte Corp | Dec 1, 2022 | 12 | $0 | 4 | Dec 9, 2022 | Former CEO, Director |
OCX | Oncocyte Corp | Aug 16, 2022 | 1 | $38.4K | 4 | Aug 18, 2022 | President & CEO, Director |
OCX | Oncocyte Corp | Mar 15, 2022 | 1 | $64.2K | 4 | Mar 17, 2022 | Chief Executive Officer, Director |
OCX | Oncocyte Corp | Mar 15, 2022 | 5 | $0 | 4 | Mar 17, 2022 | Chief Executive Officer, Director |
PRPO | Precipio, Inc. | Jan 11, 2022 | 1 | $0 | 4 | Jan 13, 2022 | Director |
PRPO | Precipio, Inc. | Aug 3, 2021 | 1 | $0 | 4 | Aug 5, 2021 | Director |
OCX | OncoCyte Corp | Jul 1, 2021 | 3 | $0 | 4 | Jul 2, 2021 | Chief Executive Officer, Director |
OCX | OncoCyte Corp | May 7, 2021 | 3 | $0 | 4 | Jul 2, 2021 | Chief Executive Officer, Director |